Abyrx receives additional FDA clearance of resorbable bone putty
Click Here to Manage Email Alerts
Key takeaways:
- Abyrx Inc. has announced additional FDA clearance of its Montage bone putty.
- The settable, resorbable putty can be used for a variety of surgical indications.
Abyrx Inc. has announced additional FDA clearance of its Montage bone putty for use as a bone void filler and cranial bone cement, according to a press release.
The Montage bone putty is a settable and resorbable putty that can be used across a variety of surgical specialties and indications, according to the release.
“These expanded clearances for Montage reflect its versatility, which is derived from its unique, self-setting and absorbable polymer,” John J. Pacifico, founding president and CEO of Abyrx, said in the release. “The product already has an impressive track record, with more than 22,000 uses since its initial FDA clearance, and we expect that these latest clearances will support its expanded use across more applications. This important milestone is a testament to the dedicated efforts of Abyrx's excellent scientific and regulatory teams, whose work is expanding the number and type of patients who have access to the benefits of Montage,” Pacifico added.
Read more about
Click Here to Manage Email Alerts